Risk of new-onset type 2 diabetes in 600 055 people after COVID-19: A cohort study
- PMID: 35112782
- PMCID: PMC9035030
- DOI: 10.1111/dom.14659
Risk of new-onset type 2 diabetes in 600 055 people after COVID-19: A cohort study
Keywords: cohort study; database research; health economics; population study; primary care; type 2 diabetes.
References
-
- Müller JA, Groß R, Conzelmann C, et al. SARS-CoV-2 infects and replicates in cells of the human endocrine and exocrine pancreas. Nat Metab. 2021. Feb;3(2):149–165. - PubMed
-
- Fignani D, Licata G, Brusco N, Nigi L, Grieco GE, Marselli L, Overbergh L, Gysemans C, Colli ML, Marchetti P, Mathieu C, Eizirik DL, Sebastiani G, Dotta F. SARS-CoV-2 Receptor Angiotensin I-Converting Enzyme Type 2 (ACE2) Is Expressed in Human Pancreatic β-Cells and in the Human Pancreas Microvasculature. Front Endocrinol (Lausanne). 2020. Nov 13;11:596898. - PMC - PubMed
-
- Wang S, Ma P, Zhang S, Song S, Wang Z, Ma Y, Xu J, Wu F, Duan L, Yin Z, Luo H, Xiong N, Xu M, Zeng T, Jin Y. Fasting blood glucose at admission is an independent predictor for 28-day mortality in patients with COVID-19 without previous diagnosis of diabetes: a multi-centre retrospective study. Diabetologia. 2020. Oct;63(10):2102–2111. - PMC - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
